|
|
Opportunities and Challenges of Swarm AI for
Decentralized Clinical Research
Swarm learning opens new opportunities for collaboration and innovation in clinical research where all members of the swarm have equal rights. Only algorithms and parameters are shared – with no central authority. Swarm creates many new opportunities in clinical research to develop new therapeutics, epidemiology, genetics research and more. Join this session to unlock swarm principals, challenges and
opportunities in clinical R&D driving wider adoption of its application(s) in the health domain.
Key learnings will include:
- Understanding the differences between federated machine vs swarm learning
- The technical, policy and application barriers when it relates to transferring significant amounts of data
- The steps and frameworks needed to drive wider understanding and adoption of the technology in clinical R&D
- The pharma perspective: where does Swarm AI offer new solutions yet to be introduced to the drug development process
|
Speakers:
- Maria Palombini, Director, Healthcare and Life Sciences Practice, IEEE SA
- Prof. Dr. Joachim L. Schultze, Director Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE); Director, Genomics & Immunoregulation, LIMES-Institute, University of Bonn Germany
- Krishnaprasad Shastry, Director, Distinguished Technologist, Hewlett Packard Enterprise (HPE)
- Vikram Shetty, Medical Director, Singapore and Asia Area Lung Cancer Lead, AstraZenec
The 5th Annual ConVerge2Xcelerate (#ConV2X) 2021 Symposium, November 9 – 11, will converge over 100 CEOs and executive leaders of healthcare systems, think tanks, health technology companies, international government policymakers, pharmaceutical companies, specialist advisors, and leading academics to participate in over 50 panel sessions.
|
ConV2X 2021 is the acclaimed health technology modernization symposium focusing on health policy, telehealth, blockchain and artificial intelligence and connectivity in a refocused
healthcare market. It is the premier destination community identifying new and cost effective paths forward through real world evidence, strategy, operations, research & trends, where healthcare leadership and breakthrough technology providers inspire and guide informed decision making for health and policy development.
|
Special thanks to ConV2X supporters
|
|
|
|
|
